Bemarituzumab, CAS 1952272-74-0

Product Description: Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Daniel Vt Catenacci, et al. Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design. Future Oncol. 2019 Jun;15(18):2073-2082.

CAS Number: 1952272-74-0

Molecular Weight: N/A

Compound Purity: 99.50

Research Area: Cancer

Solubility: H2O

Target: FGFR

• Artikelnummer: MEXHY-P99010-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99010-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK